Month: June 2007
-
McNeil-PPC et al. v. Perrigo Co., No. 05-1321 (S.D.N.Y. 2007) In an opinion released Tuesday, Judge William H. Pauley III of the U.S. District Court for the Southern District of New York ruled that McNeil’s patent on the formulation for Pepcid Complete is invalid as obvious, clearing the way for Perrigo Co. to sell its…
-
American Conference Institute plans to hold a two-day “Pharma/Biotech Patent Boot Camp” on June 21-22 in New York. According to ACI, the conference “has been designed to give new patent attorneys and patent attorneys who are new to the life sciences industries–as well as business executives in pharma and biotech companies–a strong working knowledge of essential IP…
-
In re Omeprazole Patent Litigation, No. MDL-1291 (JPML 2007) In a lengthy decision released last Thursday, Judge Barbara S. Jones upheld the validity of AstraZeneca's two formulation patents on Prilosec (U.S. Patent Nos. 4,786,505 and 4,853,230) and found that Apotex and Impax infringe the patents while Mylan and Lek (a division of Sandoz) do not. …
-
According to SCOTUSblog, Pfizer filed an emergency plea with the Supreme Court yesterday, asking the Court to delay the effect of the Federal Circuit’s rulings against Pfizer in the Norvasc case. Separately, Pfizer filed a petition for certiorari and a motion for expedited review of the Federal Circuit’s March 22 decision invalidating three claims of…
Orange Book Blog 